Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Overview
The global non-steroidal anti-inflammatory drugs (NSAIDs) market is projected to expand from USD 21.01 billion in 2023 to approximately USD 33.55 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.0% from 2024 to 2032.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5132
Report Highlights:
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Companies
Key players in the non-steroidal anti-inflammatory drugs (NSAIDs) market include:
- Pfizer Inc.: A global leader in the pharmaceutical industry, Pfizer manufactures a variety of NSAIDs for pain and inflammation management.
- Merck & Co., Inc.: Merck offers innovative NSAID solutions and has a strong presence in the global market with several pain relief products.
- Novartis AG: A multinational pharmaceutical company, Novartis provides NSAID treatments for chronic and acute inflammatory conditions.
- GlaxoSmithKline Plc: Known for its broad portfolio, GSK is involved in the development and marketing of NSAIDs for various therapeutic applications.
- Johnson & Johnson Services Inc.: With a focus on pain management, J&J is a key player in the NSAID market, offering over-the-counter and prescription solutions.
- Bayer AG: A leading company in the healthcare sector, Bayer produces NSAIDs for the treatment of pain, fever, and inflammation.
- Dr. Reddy’s Laboratories Ltd.: Dr. Reddy’s is a prominent generic drug manufacturer that supplies affordable NSAID options globally.
- Viatris Inc.: Viatris provides a range of NSAIDs, with a focus on accessibility and affordability in the global market.
- AstraZeneca: AstraZeneca is involved in the development of NSAIDs for pain relief, particularly in the context of arthritis and other chronic conditions.
- Abbott Laboratories: Abbott offers NSAID products targeted at managing pain and inflammation, with a strong focus on both prescription and over-the-counter formulations.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/non-steroidal-anti-inflammatory-drugs-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5132
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare